HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM

por Chang, Hae Yeun, Huynh, Mailee, Roopra, Avtar, Callander, Natalie S., Miyamoto, Shigeki
Publicado 2023

HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs

por Huynh, Mailee, Chang, Hae Yeun, Lisiero, Dominique N., Ong, Irene M., Kashyap, Trinayan, Callander, Natalie S., Miyamoto, Shigeki
Publicado 2022